Strikingly, our findings suggest that the wild‐type p53‐modulated METTL14 can be tumor suppressive in the context of wild‐type p53 yet displays no significant effects in p53‐MT or p53‐null CRC cells. This evidence concerns the gene TP53 and neoplasm.